People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| LinguaFlex, Inc. | — | Other Health Care | Series B | $23.8M | $79.8M | 2009 |
| Rose Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $650K | $9.5M | 2022 |
Ira Sanders at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ira Sanders on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Timothy Langloss | 2 | 7 |
| John Miclot | 1 | 5 |
| Matthew Wotiz | 1 | 4 |
| William Doyle | 1 | 4 |
| Michele Ollier | 1 | 4 |
| Remy Luthringer | 1 | 2 |
| Cliff Dwyer | 1 | 1 |
| Mark Funston | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.